F Kradolfer, R Schnell. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsDrug Resistance, MicrobialFemaleIsoniazid/therapeutic useMiceMutation/drug effectsMycobacterium bovis/drug effectsRifampin/therapeutic useTuberculosis, Pulmonary/drug therapy
Substances: See more » IsoniazidRifampin
Year: 1970 PMID: 4919029 DOI: 10.1159/000220688
Source DB: PubMed Journal: Chemotherapy ISSN: 0009-3157 Impact factor: 2.544